Your Location：
Home >
Browse articles >
Effect of Modified Liu Junzitang and Erchentang on Hcy， NO， hs-CRP in Patients with Coronary Heart Disease
Effect of Modified Liu Junzitang and Erchentang on Hcy， NO， hs-CRP in Patients with Coronary Heart Disease
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 18, Pages: 24-29(2020)
DOI： 10.13422/j.cnki.syfjx.20201723
Scan QR Code
Full Text(HTML)
Figs( 0 ) Tabs( 9 )
References
Publication Info
Metrics
134
Views
70
Downloads
2
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Traditional Chinese Medicine Treats Coronary Heart Disease by Intervening in Cardiovascular Cell Apoptosis： A Review
Erchentang Alleivates Depression in Obese Mice by Regulating PPAR Signaling Pathway
Exploring Potential Biomarkers of Blood Stasis Syndrome in Coronary Heart Disease and Association Between Platelet Metabolic Disorder and Myocardial Injury Based on Platelet Metabolomics
Xuefu Zhuyutang Treats Coronary Heart Disease with Blood Stasis Syndrome in Rats via SIRT3 Signaling Pathway-mediated Regulation of Endothelial Function
Erchentang Ameliorates SiO2-induced Lung Injury by Regulating Oxidative Stress and Metabolic Disorders via Nrf2/HO-1 Signaling Pathway
Related Author
ZHOU Zhenlong
DUAN Yu
SHA Hongyu
ZHOU Haichun
YU Qiao
HU Shiwei
ZHANG Jinrong
XU Jun
Related Institution
The Second Clinical Medical College， Heilongjiang University of Chinese Medicine
Shandong University of Traditional Chinese Medicine
Shanghai Haijiang Geriatric Hospital
The Fourth Affiliated Hospital of Heilongjiang University of Chinese Medicine
Central Theater Command General Hospital of the People's Liberation Army
Chat
